Tag: Migraine
Chronic migraine
Diagnostic criteria for chronic migraine defined by the International Headache Society. (Headache Classification Comittee. The International Classification of Headache Disorders : 3rd edition beta versin. Cephalalgia 2013; 33:629-808). A. Headache present at least 15 days per
migraine MEDECIN LIBRE
Diagnostic Migraine management: aims to accurately diagnose migraine according to ICHD-3 criteria, check chronic migraine risk factors and comorbidities, to assess migraine-related problems disability and its severity, to evaluate the effectiveness and tolerability of current
Migraine aura MEDECIN
Migraine aura may not be followed by headache, posing difficult diagnostic problems, especially in the absence of an identical history. Visual aura It is the most common aura; it characterizes “ophthalmic migraine”. The scintillating scotoma
Temporal criteria of migraines and tension headaches. MEDECIN
Minimum number of crisis for diagnosis Duration of crisis Crisis Frequency Aura Onset Duration Aura Duration Migraine without aura 5 24-72 h Migraine with aura 2 >5
Triptans
Reference treatment for migraine attacks. Several molecules are available: The development of anti-CGRP antibodies modifies the prescription of triptans in the management of migraine. Almotriptan, Eletriptan, Frovatriptan, Naratritan, Rizatriptan, Sumatriptan, Zolmitriptan. Trade name in order:
Temporal criteria for migraines and tension headaches ABONNE
Minimum number of crisis for diagnosis Duration of crisis Crisis Frequency Aura Onset Duration Aura Duration Migraine without aura 5 24-72 h Migraine with aura 2 >5
Migraine aura ABONNE
Migraine aura may not be followed by headache, posing difficult diagnostic problems, especially in the absence of an identical history. Visual aura It is the most common aura; it characterizes “ophthalmic migraine”. The scintillating scotoma
Migraine ABONNE LIBRE
Diagnostic Migraine management: aims to accurately diagnose migraine according to ICHD-3 criteria, check chronic migraine risk factors and comorbidities, to assess migraine-related problems disability and its severity, to evaluate the effectiveness and tolerability of current